Nutex Health (NUTX)
(Delayed Data from NSDQ)
$10.10 USD
+2.20 (27.85%)
Updated Aug 9, 2024 03:59 PM ET
After-Market: $9.95 -0.15 (-1.48%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
NUTX 10.10 +2.20(27.85%)
Will NUTX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NUTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NUTX
InnovAge Holding Corp. (INNV) Reports Q1 Loss, Tops Revenue Estimates
Nutex Health Inc. (NUTX) Reports Q2 Loss, Lags Revenue Estimates
NUTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Enhabit (EHAB) Lags Q2 Earnings and Revenue Estimates
Agiliti (AGTI) Q2 Earnings Lag Estimates
Pediatrix Medical Group (MD) Meets Q2 Earnings Estimates
Other News for NUTX
Nutex Health (NUTX) Q2 2024 Earnings Call Transcript
NUTX Stock Earnings: Nutex Health Misses EPS, Beats Revenue for Q2 2024
Nutex Health GAAP EPS of -$0.07, revenue of $76.1M
NUTEX HEALTH REPORTS SECOND QUARTER AND SIX MONTHS ENDED JUNE 30, 2024 FINANCIAL RESULTS
NUTEX HEALTH SCHEDULES 2024 SECOND QUARTER FINANCIAL RESULTS RELEASE AND CONFERENCE CALL